je.st
news
Tag: bristolmyers
FDA expands lung cancer approval for Bristol-Myers' drug
2015-10-10 01:17:07| Biotech - Topix.net
The U.S. Food and Drug Administration on Friday expanded its approval of Bristol-Myers Squibb Co's immunotherapy drug Opdivo for patients with an additional form of advanced lung cancer. The agency said Opdivo may now be used in patients with non-squamous non-small cell lung cancer whose disease has progressed during or after platinum-based chemotherapy.
Tags: drug
approval
cancer
lung
Bristol-Myers' gets early approval of combo cancer treatment
2015-10-01 20:40:07| Biotech - Topix.net
The first combination of breakthrough drugs that boost the immune system to fight cancer has been approved, giving maker Bristol-Myers Squibb an early lead over competitors testing their own combos in a pharmaceutical gold rush of sorts. The Food and Drug Administration has given accelerated approval to a regimen combining the New York-based drugmaker's two immuno-oncology drugs, Opdivo and Yervoy, to treat patients with advanced melanoma who have a particular genetic variation.
Tags: early
treatment
approval
cancer
Bristol-Myers to Buy Fibrosis Drug Rights, Exelon Reaffirmed Pepco Pursuit
2015-08-31 20:17:43| Steel - Topix.net
Exelon reaffirmed to acquire Pepco Holdings. HealthSouth plans to acquire CareSouth Health for $170 million.
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015
2015-08-24 22:52:31| Biotech - Topix.net
Bristol-Myers Squibb Company and Pfizer Inc. announced today that 22 abstracts will be presented at the Congress 2015, to be held August 29 to September 2 in London, United Kingdom. The new data reinforce the Alliance's commitment to the ongoing evaluation of Eliquis in both the nonvalvular atrial fibrillation and venous thromboembolism patient populations.
Tags: the
data
present
congress
Bristol-Myers wins approval for 1st hepatitis C type 3 drug
2015-07-24 22:19:25| Biotech - Topix.net
An experimental drug for one of the most difficult-to-treat types of hepatitis C has been approved by the Food and Drug Administration, adding to the surge of new options for patients with the liver-destroying virus. Daklinza , developed by New York-based Bristol-Myers Squibb Co., is the first drug approved to treat genotype 3 hepatitis C. It's to be used with Sovaldi, one of two blockbuster hepatitis C drugs sold by Gilead Sciences, along with Harvoni.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »